Literature DB >> 21680501

A recombinant vesicular stomatitis virus bearing a lethal mutation in the glycoprotein gene uncovers a second site suppressor that restores fusion.

Megan L Stanifer1, David K Cureton, Sean P J Whelan.   

Abstract

Vesicular stomatitis virus (VSV), a prototype of the Rhabdoviridae family, contains a single surface glycoprotein (G) that is responsible for attachment to cells and mediates membrane fusion. Working with the Indiana serotype of VSV, we employed a reverse genetic approach to produce fully authentic recombinant viral particles bearing lethal mutations in the G gene. By altering the hydrophobicity of the two fusion loops within G, we produced a panel of mutants, W72A, Y73A, Y116A, and A117F, that were nonfusogenic. Propagation of viruses bearing those lethal mutations in G completely depended on complementation by expression of the glycoprotein from the heterologous New Jersey serotype of VSV. The nonfusogenic G proteins oligomerize and are transported normally to the cell surface but fail to mediate acid pH-triggered membrane fusion. The nonfusogenic G proteins also interfered with the ability of wild-type G to mediate fusion, either by formation of mixed trimers or by inhibition of trimer function during fusion. Passage of one recombinant virus, A117F, identified a second site suppressor of the fusion block, E76K. When analyzed in the absence of the A117F substitution, E76K rendered G more sensitive to acid pH-triggered fusion, suggesting that this compensatory mutation is destabilizing. Our work provides a set of authentic recombinant VSV particles bearing lethal mutations in G, confirms that the hydrophobic fusion loops of VSV G protein are critical for membrane fusion, and underscores the importance of the sequence elements surrounding the hydrophobic tips of the fusion loops in driving fusion. This study has implications for understanding dominant targets for inhibition of G-mediated fusion. Moreover, the recombinant viral particles generated here will likely be useful in dissecting the mechanism of G-catalyzed fusion as well as study steps of viral assembly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680501      PMCID: PMC3147994          DOI: 10.1128/JVI.00735-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Synchronised transmembrane insertion and glycosylation of a nascent membrane protein.

Authors:  J E Rothman; H F Lodish
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

2.  Coinfection with a rhabdovirus: vesicular stomatitis virus of Indiana and New-Jersey serotypes.

Authors:  F Bussereau; A Flamand
Journal:  Ann Microbiol (Paris)       Date:  1978-07

3.  The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.

Authors:  L Lefrancios; D S Lyles
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

4.  Pathway of vesicular stomatitis virus entry leading to infection.

Authors:  K S Matlin; H Reggio; A Helenius; K Simons
Journal:  J Mol Biol       Date:  1982-04-15       Impact factor: 5.469

5.  Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses.

Authors:  Sara B Sieczkarski; Gary R Whittaker
Journal:  Traffic       Date:  2003-05       Impact factor: 6.215

6.  Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?

Authors:  R Schlegel; T S Tralka; M C Willingham; I Pastan
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

7.  Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.

Authors:  David A Coil; A Dusty Miller
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity.

Authors:  E Jeetendra; Kakoli Ghosh; Derek Odell; Jin Li; Hara P Ghosh; Michael A Whitt
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein.

Authors:  J K Rose; J E Bergmann
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

10.  Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses.

Authors:  J White; K Matlin; A Helenius
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

View more
  15 in total

Review 1.  Oncolytic viruses: From bench to bedside with a focus on safety.

Authors:  Pascal R A Buijs; Judith H E Verhagen; Casper H J van Eijck; Bernadette G van den Hoogen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Structural intermediates in the fusion-associated transition of vesiculovirus glycoprotein.

Authors:  Eduard Baquero; Aurélie A Albertini; Hélène Raux; Abbas Abou-Hamdan; Elisabetta Boeri-Erba; Malika Ouldali; Linda Buonocore; John K Rose; Jean Lepault; Stéphane Bressanelli; Yves Gaudin
Journal:  EMBO J       Date:  2017-02-10       Impact factor: 11.598

3.  Mechanism of membrane fusion induced by vesicular stomatitis virus G protein.

Authors:  Irene S Kim; Simon Jenni; Megan L Stanifer; Eatai Roth; Sean P J Whelan; Antoine M van Oijen; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-14       Impact factor: 11.205

Review 4.  Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

Authors:  Eric Hastie; Valery Z Grdzelishvili
Journal:  J Gen Virol       Date:  2012-10-10       Impact factor: 3.891

5.  Functional analysis of the Autographa californica multiple nucleopolyhedrovirus GP64 terminal fusion loops and interactions with membranes.

Authors:  Sicong Dong; Gary W Blissard
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

6.  Characterization of pH-sensitive molecular switches that trigger the structural transition of vesicular stomatitis virus glycoprotein from the postfusion state toward the prefusion state.

Authors:  Anna Ferlin; Hélène Raux; Eduard Baquero; Jean Lepault; Yves Gaudin
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

7.  Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.

Authors:  Lindsey R Robinson; Sean P J Whelan
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

8.  A novel rhabdovirus associated with acute hemorrhagic fever in central Africa.

Authors:  Gilda Grard; Joseph N Fair; Deanna Lee; Elizabeth Slikas; Imke Steffen; Jean-Jacques Muyembe; Taylor Sittler; Narayanan Veeraraghavan; J Graham Ruby; Chunlin Wang; Maria Makuwa; Prime Mulembakani; Robert B Tesh; Jonna Mazet; Anne W Rimoin; Travis Taylor; Bradley S Schneider; Graham Simmons; Eric Delwart; Nathan D Wolfe; Charles Y Chiu; Eric M Leroy
Journal:  PLoS Pathog       Date:  2012-09-27       Impact factor: 6.823

9.  Molecular and cellular aspects of rhabdovirus entry.

Authors:  Aurélie A V Albertini; Eduard Baquero; Anna Ferlin; Yves Gaudin
Journal:  Viruses       Date:  2012-01-18       Impact factor: 5.048

10.  Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.

Authors:  Kalliopi Pervolaraki; Megan L Stanifer; Stephanie Münchau; Lynnsey A Renn; Dorothee Albrecht; Stefan Kurzhals; Elena Senís; Dirk Grimm; Jutta Schröder-Braunstein; Ronald L Rabin; Steeve Boulant
Journal:  Front Immunol       Date:  2017-04-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.